SecBot SecBot
8-K ·Filed Apr 6, 2026

HOLX

HOLOGIC INC
NEUTRAL
Impact 7/10
Horizonimmediate Processed7mo ago SEC0001140361-26-013235
8-K context-dependent: Items 5.02, 8.01
Actionable Insight • Neutral

The stock will likely be delisted following the closing on April 7, 2026. Traders should position accordingly as the company transitions to private ownership. The retirement of the long-tenured CEO signals a significant leadership transition coinciding with the ownership change.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK AT ENTRY AT T+1
Entry
$76.01
T+0 close · Apr 6, 2026 · via day close
Latest settled
0.00%
T+1 · $76.01
Vs SPY
−0.06%
α at T+1
Next horizon
T+5
due 7mo ago
  1. T+0 · Apr 6 $76.01entry
  2. T+1 · 7mo ago 0.00%α −0.06% · $76.01
  3. T+5 · due 7mo ago Pending
  4. T+20 · due 7mo ago Pending
  5. T+60 · due 5mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Hologic CEO Stephen MacMillan announced his retirement effective upon the closing of the company's acquisition by Blackstone and TPG, following receipt of all required regulatory approvals. The go-private transaction is expected to close on April 7, 2026.

Key Facts

  • CEO Stephen MacMillan is retiring contingent upon the closing of the Blackstone/TPG acquisition
  • All regulatory approvals for the merger have been received
  • Transaction expected to close on or about April 7, 2026
  • MacMillan served as CEO since 2013 and led significant growth in revenue, EPS, and share price
  • Next CEO will be announced at closing

Financial Impact

The acquisition represents a full change in ownership structure from public to private, removing the company from public markets. The filing confirms regulatory approval but does not disclose the transaction value.

ownership structureexecutive leadershipregulatory status

Risk Factors

  • Risk that merger conditions are not satisfied despite regulatory approval
  • Potential disruption from CEO transition and go-private process
  • Uncertainty around future leadership and strategy under new ownership

Market Snapshot

Exchange
Nasdaq
Sector
X-Ray Apparatus & Tubes & Related Irradiation Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-013235
Document: ef20069327_ex99-1.htm0001140361-26-013235
Document: 0001140361-26-013235-index-headers.html0001140361-26-013235
Document: 0001140361-26-013235-index.html0001140361-26-013235
Document: 0001140361-26-013235.txt0001140361-26-013235

Track record

5 reports on HOLX

Performance horizon
Filters
  1. Apr 17, 202630w ago 15-12G Neutral 7/10 No price data
  2. Apr 13, 202631w ago EFFECT Neutral 3/10 No price data
  3. Apr 7, 202631w ago 8-K Neutral 9/10 Entry $76.01 No price data
  4. Apr 6, 202632w ago 8-K Neutral 7/10 Viewing Entry $76.01 No price data
  5. Feb 28, 202637w ago Institutional Cluster Mixed 6/10 Entry $75.45 to $75.55 ▲ +0.13% +8.07% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens Wed (11h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 6, 2026